2025-2034 Tumor Ablation Therapy Devices Market Outlook: Key Drivers, Emerging Challenges, and Strategic Insights

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Tumor Ablation Therapy Devices Industry Market Size Be by 2025?
The market size for devices used in tumor ablation therapy has seen swift growth in recent times. The market, currently valued at $0.72 billion as of 2024, is projected to escalate to a value of $0.82 billion by 2025, demonstrating a compound annual growth rate (CAGR) of 14.2%. The surge during the historic period can be tied to factors such as increased occurrence of cancer, technological progression, an ageing populace, and the rise of minimally invasive procedures.

What's the Long-Term Growth Forecast for the Tumor Ablation Therapy Devices Market Size Through 2029?
The market for tumor ablation therapy devices is set to witness a swift expansion in the coming years, with its size predicted to reach $1.42 billion by 2029, growing at a compound annual growth rate (CAGR) of 14.6%. Factors influencing this growth for the predicted period include personalized medicine, combination therapies, AI assisted and image-guided ablation, telemedicine, remote consultations, as well as training and education. The forecast period will also see emerging trends like technological advancements in ablation, imaging guidance, assistance from robotics and navigation, incorporation of immuno-oncology, and the execution of percutaneous and image-guided ablation.

View the full report here:
https://www.thebusinessresearchcompany.com/report/tumor-ablation-therapy-devices-global-market-report

What Are the Key Growth Drivers Fueling the Tumor Ablation Therapy Devices Market Expansion?
The rise in cancer occurrences is a critical element propelling the expansion of the tumor ablation therapy devices market. Globally, cancer is seen as the second leading cause of death, responsible for around 1 out of 6 fatalities. Utilized a great deal in addressing lung, liver, kidney, and bone tumors, tumor ablation is a minimally invasive process. For example, projections by the American Cancer Society Inc., a non-profit health organization based in the US, anticipate that 1,958,310 new cancer cases will arise in the US in 2023, marking a growth from the 1,918,030 new cases seen in 2022. This procedure serves as an effective treatment for individuals whose chemotherapy or radiotherapy did not bring success, consequently bolstering the growth of the tumor ablation therapy devices market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3351&type=smp

Which Emerging Trends Are Transforming the Tumor Ablation Therapy Devices Market in 2025?
Top enterprises engaged in the production of tumor ablation therapy devices are concentrating on technological enhancements to shorten the procedures, boost safety, reduce radiation exposure, accelerate learning curves, and enhance outcomes. For instance, J&J medicals have released a microwave ablation system called NEUWAVE. This marks the first minimally invasive gadget designed to insert electrodes into cancer cells, thereby raising the temperature around them to destroy the cells. In another development, in April 2023, Compal Electronics, a Taiwan-based electronics manufacturer, introduced AblatePal, a fresh radiofrequency ablation (RFA) mechanism crafted for percutaneous, intraoperative coagulation, and ablation of soft tissue. This includes the partial or total therapy of non-resectable liver lesions. AblatePal works by leveraging the heat energy created due to electrical resistance as the current flows through the tissue, leading ultimately to the removal of the specific targeted tissue. This system is utilized in therapeutic medical devices and is skillfully designed to tackle a broad spectrum of medical conditions, principally cancer.

How Is the Tumor Ablation Therapy Devices Market Segmented?
The tumor ablation therapy devices market covered in this report is segmented -

1) By Technology: Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation, Other Technologies
2) By Treatment: Surgical, Laparoscopic, Percutaneous
3) By Application: Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Other Applications
4) By End User: Hospitals, Oncology Clinics, Other End Users

Subsegments:
1) By Radiofrequency Ablation (RFA): Monopolar RFA Devices, Bipolar RFA Devices
2) By Microwave Ablation: High-frequency Microwave Devices, Low-frequency Microwave Devices
3) By Cryoablation: Liquid Nitrogen-based Devices, Argon Gas-based Devices
4) By Irreversible Electroporation Ablation (IRE): NanoKnife Ablation Systems, High-voltage Pulse Generators
5) By Other Technologies: Laser Ablation Devices, Ultrasound-guided High-intensity Focused Ultrasound (HIFU), Chemical Ablation Techniques

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=3351&type=smp

Which Companies Are Leading the Charge in Tumor Ablation Therapy Devices Market Innovation?
Major companies operating in the tumor ablation therapy devices market include Galil Medical Inc., Misonix Inc., HealthTronics Inc., AngioDynamics Inc., Boston Scientific Corporation, Medtronic plc, EDAP TMS S.A., NeuWave Medical Inc., BVM Medical Limited, Erbe Elektromedizin GmbH, AtriCure Inc., Theraclion, INTIO Inc., BIOTRONIK SE & Co. KG, Olympus Corporation, Stryker Corporation, Merit Medical Systems Inc., Insightec Ltd., Terumo Corporation, Smith & Nephew plc, Monteris Medical Corporation, IceCure Medical Ltd., Profound Medical Inc., Alpinion Medical Systems Co. Ltd., Sonacare Medical, Hologic Inc., Endocare Inc., Integra LifeSciences Corporation, Bovie Medical Corporation

Which Regions Are Leading the Global Tumor Ablation Therapy Devices Market in Revenue?
North America was the largest region in the tumor ablation therapy devices market in 2024. Asia-Pacific was the second largest region in the tumor ablation therapy devices market. The regions covered in the tumor ablation therapy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3351

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.